Sarepta Therapeutics (SRPT) EBT Margin Growth (5y) (2017 - 2026)
Sarepta Therapeutics (SRPT) EBT Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,088.00 |
| Dec 31, 2025 | 6,704.00 |
| Sep 30, 2025 | 11,315.00 |
| Jun 30, 2025 | 13,492.00 |
| Mar 31, 2025 | -27,235.00 |
| Dec 31, 2024 | 26,081.00 |
| Sep 30, 2024 | 13,460.00 |
| Jun 30, 2024 | 29,553.00 |
| Mar 31, 2024 | 9,801.00 |
| Dec 31, 2023 | 17,157.00 |
| Sep 30, 2023 | 8,747.00 |
| Jun 30, 2023 | 14,217.00 |
| Mar 31, 2023 | -16,695.00 |
| Dec 31, 2022 | 8,405.00 |
| Sep 30, 2022 | -1,186.00 |
| Jun 30, 2022 | 7,241.00 |
| Mar 31, 2022 | -58,196.00 |
| Dec 31, 2019 | 16.56 Mn |
| Sep 30, 2019 | 344,596.00 |
| Jun 30, 2019 | 104,855.00 |